Current studies of biomarkers for the early diagnosis of rheumatoid arthritis

References

• Finckle A, Liang MH, van Herckenrode CM, de Pablo P. Long term impact of early treatment on radiological progression in rheumatoid arthritis: A meta-analysis. Arthritis Rheum. 2006;55:864–872.
   Google Scholar
• van Aken J, van Dongen H, le Cessie S, Allaart CF, Breedveld FC, Huizinga TW. Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study. Ann Rheum Dis. 2006;65:20–25.
   PubMed Web of Science ®Google Scholar
• Hazes JM, Luime JJ. The epidemiology of early inflammatory arthritis. Nat Rev Rheumatol. 2011;7:381–390.
   PubMed Web of Science ®Google Scholar
• Machado P, Castrejon I, Katchamart W, et al. Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative. Ann Rheum Dis. 2011;70(1):15–24.
   Web of Science ®Google Scholar
• Olivieri I, Sarzi-Puttini P, Bugatti S, Atzeni F, d’Angelo S, Caporali R. Early treatment in early undifferentiated arthritis. Autoimmune Rev. 2012;11(8):589–592.
   Web of Science ®Google Scholar
• Chandrashekara S. Pharmacokinetic consideration of synthetic DMARDs in rheumatoid arthritis. Expert Opin Drug Metab Toxicol. 2013;9(8):969–981.
   PubMed Web of Science ®Google Scholar
• Rantapää-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48(10):2741–2749.
   PubMedGoogle Scholar
• Weyand CM, Goronzy JJ. Association of MHC and rheumatoid arthritis. HLA polymorphisms in phenotypic variants of rheumatoid arthritis. Arthritis Res. 2000;2(3):212–216.
   Google Scholar
• Kang YM, Zhang X, Wagner UG, et al. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J Exp Med. 2002;195:1325–1336.
   PubMed Web of Science ®Google Scholar
• Gorman JD, Lum RF, Chen JJ, Suarez-Almazor ME, Thomson G, Criswell LA. Impact of shared epitope genotype and ethnicity on erosive disease: a meta-analysis of 3,240 rheumatoid arthritis patients. Arthritis Rheum. 2004;50(2):400–412.
   PubMed Web of Science ®Google Scholar
• Schotte H, Schlüter B, Drynda S, et al. Interleukin 10 promoter microsatellite polymorphisms are associated with response to long term treatment with etanercept in patients with rheumatoid arthritis. Ann Rheumatic Dis. 2005;64(4):575–581.
   PubMed Web of Science ®Google Scholar
• Sen M. Wnt signalling in rheumatoid arthritis. Rheumatology (Oxford). 2005;44(6):708–713.
   Web of Science ®Google Scholar
• Marinou I, Healy J, Mewar D, et al. Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status. Arthritis Rheum. 2007;56(8):2549–2556.
   Google Scholar
• Kallberg H, Padyukov L, Plenge RM, et al. Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22 and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet. 2007;80:867–875.
   PubMed Web of Science ®Google Scholar
• Pratt AG, Swan DC, Richardson S, et al. A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease. Ann Rheum Dis. 2012;71:1374–1381.
   PubMed Web of Science ®Google Scholar
• Berglin E, Padyukov L, Sundin U, et al. A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis. Arthritis Res Ther. 2004;6(4):R303–R308.
   PubMed Web of Science ®Google Scholar
• Johansson M, Arlestig L, Hallmans G, Rantapää-Dahlqvist S. PTPN22 polymorphism and anti-cyclic citrullinated peptide antibodies in combination strongly predicts future onset of rheumatoid arthritis and has a specificity of 100% for the disease. Arthritis Res Ther. 2006;8(1):R19.
   Web of Science ®Google Scholar
• Scott IC, Seegobin SD, Steer S, et al. Predicting the risk of rheumatoid arthritis and its age of onset through modeling genetic risk variants with smoking. PLoS Genet. 2013;9(9):e1003808.
   Web of Science ®Google Scholar
• van Baarsen LG, de Hair MJ, Ramwadhdoebe TH, et al. The cellular composition of lymph nodes in the earliest phase of inflammatory arthritis. Ann Rheum Dis. 2013;72:1420–1424.
   PubMed Web of Science ®Google Scholar
• Lawson CA, Brown AK, Bejarano V, et al. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. Rheumatology (Oxford). 2006;45:1210–1217.
   PubMed Web of Science ®Google Scholar
• Arroyo-Villa I, Bautista-Caro MB, Balsa A, et al. Frequency of th17 CD4+ T cells in early rheumatoid arthritis: a marker of anti-CCP seropositivity. PLoS One. 2012;7(8):e42189.
   PubMed Web of Science ®Google Scholar
• Pawłowska J, Smolenska Ż, Zdrojewski Z, Witkowski JM, Bryl E. Changes in proliferation kinetics of T cells: A new predictive cellular biomarkers for early rheumatoid arthritis? J Clin Immunol. 2012;32:991–999.
   Google Scholar
• Goëb V, Aegerter P, Parmar R, et al. Progression to rheumatoid arthritis in early inflammatory arthritis is associated with low IL-7 serum levels. Ann Rheum Dis. 2013;72:1032–1036.
   PubMedGoogle Scholar
• Lübbers J, Brink M, van de Stadt LA, et al. The type I IFN signature as a biomarker of preclinical rheumatoid arthritis. Ann Rheum Dis. 2013;72:776–780.
   PubMed Web of Science ®Google Scholar
• Solanki K, Spellerberg M, Chapman P, Moller P, O’Donnell J. Anti-cyclic citrullinated antibodies: complementary to IgM rheumatoid factor in the early diagnosis of rheumatoid arthritis. N Z Med J. 2004;117(1203):U1097.
   Google Scholar
• Mouterde G, Lukas C, Logeart I, et al. Predictors of radiographic progression in the ESPOIR cohort: the season of first symptoms may influence the short-term outcome in early arthritis. Ann Rheum Dis. 2011;70(7):1251–1256.
   Web of Science ®Google Scholar
• Liu X, Jia R, Zhao J, Li Z. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis. J Rheumatol. 2009;36(6):1136–1142.
   Web of Science ®Google Scholar
• Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B; BARFOT Study Group. Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP). Ann Rheum Dis. 2004;63:1090–1095.
   PubMed Web of Science ®Google Scholar
• Kastbom A, Strandberg G, Lindroos A, Skogh T. Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis. 2004;63:1085–1089.
   PubMed Web of Science ®Google Scholar
• Li GY, Sun XL, Li Y, Jia RL, Jia Y, Li ZG. [Significance of anti-citrullinated human papilloma virus-47 E2(345–362) peptide antibodies in diagnosis of early-stage rheumatoid arthritis]. Beijing Da Xue Xue Bao. 2013;45(3):458–463. Chinese.
   Google Scholar
• Damjanovska L, Thabet MM, Levarth EW, et al. Diagnostic value of anti-MCV antibodies in differentiating early inflammatory arthritis. Ann Rheum Dis. 2010;69:730–732.
   PubMed Web of Science ®Google Scholar
• Pratt AG, Charles PJ, Chowdhury M, Wilson G, Venables PJ, Isaacs JD. Serotyping for an extended anti-citrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohort. Ann Rheum Dis. 2011;70:2056–2058.
   PubMed Web of Science ®Google Scholar
• Strollo R, Ponchel F, Malmström V, et al. Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis. Arthritis Rheum. 2013;65(7):1702–1712.
   PubMedGoogle Scholar
• Cook A, Rowley M, Mackay M, inventors; Montech Medical Developments Pty Ltd, assignee. Method for detecting rheumatoid arthritis employing the CB10 peptide of mammalian type II collagen as an antigen. United States patent US 6706490 B1. March 16, 2004.
   Google Scholar
• Blass S, Union A, Raymackers J, et al. The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. Arthritis Rheum. 2001;44(4):761–771.
   PubMed Web of Science ®Google Scholar
• Saulot V, Vittecoq O, Charlionet R, et al. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum. 2002;46(5):1196–1201.
   Google Scholar
• Bugatti S, Manzo A, Benaglio F, et al. Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs. Arthritis Res Ther. 2012;14:R34.
   PubMed Web of Science ®Google Scholar
• Roy S, Biswas S, Saroha A, Sahu D, Das HR. Enhanced expression and fucosylation of ficolin3 in plasma of RA patients. Clin Biochem. 2013;46(1–2):160–163.
   Web of Science ®Google Scholar
• Ni M, Wei W, Feng Q, et al. Transthyretin as a potential serological marker for the diagnosis of patients with early rheumatoid arthritis. Clin Experimental Rheumatol. 2013;31:394–399.
   PubMed Web of Science ®Google Scholar
• Di Franco M, Spinelli FR, Metere A, et al. Serum levels of asymmetric dimethylarginine and apelin as potential markers of vascular endothelial dysfunction in early rheumatoid arthritis. Mediators Inflamm. 2012;2012:347268.
   Web of Science ®Google Scholar
• Zeidler H. Systemic literature review of the performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: good news of debatable significance. Ann Rheum Dis. 2013;72(8):e21.
   Web of Science ®Google Scholar
• Radner H, Neogi T, Smolen JS, Aletaha D. Performance of the 2010 ACR/EULAR classification criteria for rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2014;73(1):114–123.
   PubMed Web of Science ®Google Scholar
• Niewold TB, Harrison MJ, Paget SA. Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis. QJM. 2007;100(4):193–201.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Sugiyama D, Kogata Y, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146(11):797–808.
   PubMed Web of Science ®Google Scholar
• Tedesco A, D’Agostino D, Soriente I, Amato P, Piccoli R, Sabatini P. A new strategy for the early diagnosis of rheumatoid arthritis: a combined approach. Autoimmun Rev. 2009;8(3):233–237.
   Web of Science ®Google Scholar
• Panchagnula R, Rajiv SR, Prakash J, Chandrashekara S, Suresh KP. Role of anti-cyclic citrullinated peptide in the diagnosis of early rheumatoid factor-negative suspected rheumatoid arthritis: is it worthwhile to order the test? J Clin Rheumatol. 2006;12(4):172–175.
   Web of Science ®Google Scholar
• Shi J, van de Stadt LA, Levarht EW, et al. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Arthritis Rheum. 2013;65(4):911–915.
   PubMedGoogle Scholar
• Shi J, van de Stadt LA, Levarht EW, et al. Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis. Ann Rheum Dis. 2014;73(4):780–783.
   Web of Science ®Google Scholar
• Rantapää-Dahlqvist S, Boman K, Tarkowski A, Hallmans G. Up regulation of monocyte chemoattractant protein-1 expression in anti-citrulline antibody and immunoglobulin M rheumatoid factor positive subjects precedes onset of inflammatory response and development of overt rheumatoid arthritis. Ann Rheum Dis. 2007;66(1):121–123.
   Web of Science ®Google Scholar
• Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum. 2002;46(2):357–365.
   PubMed Web of Science ®Google Scholar
• Krabben A, Abhishek A, Britsemmer K, et al. Risk of rheumatoid arthritis development in patients with unclassified arthritis according to the 2010 ACR/EULAR criteria for rheumatoid arthritis. Rheumatology (Oxford). 2013;52(7):1265–1270.
   Web of Science ®Google Scholar
• Söderlin MK, Kastbom A, Kautiainen H, Leirisalo-Repo M, Strandberg G, Skogh T. Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity. Scand J Rheumatol. 2004;33(3):185–188.
   PubMed Web of Science ®Google Scholar
• Aho K, Palosuo T, Knekt P, Alha P, Aromaa A, Heliövaara M. Serum C-reactive protein does not predict rheumatoid arthritis. J Rheumatol. 2000;27(5):1136–1138.
   Web of Science ®Google Scholar
• Kuriya B, Cheng CK, Chen HM, Bykerk VP. Validation of a prediction rule for development of rheumatoid arthritis in patients with early undifferentiated arthritis. Ann Rheum Dis. 2009;68:1482–1485.
   PubMed Web of Science ®Google Scholar
• Gottenberg JE, Dayer JM, Lukas C, et al. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort. Ann Rheum Dis. 2012;71:1243–1248.
   PubMed Web of Science ®Google Scholar
• Billiavska I, Stamm TA, Martinez-Avila J, et al. Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort. Ann Rheum Dis. 2013;72:1335–1341.
   Web of Science ®Google Scholar
• van der Helm-van Mil AH, le Cessie S, van Dongen H, Breedveld FC, Toes RE, Huizinga TW. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum. 2007;56(2):433–440.
   PubMedGoogle Scholar
• Tamai M, Kawakami A, Uetani M, et al. Magnetic resonance imaging (MRI) detection of synovitis and bone lesions of the wrists and finger joints in early-stage rheumatoid arthritis: comparison of accuracy of plain MRI-based findings and gadolinium-diethylenetriamine pentaacetic acid-enhanced MRI-based findings. Mod Rheumatol. 2012;22(5):654–658.
   PubMed Web of Science ®Google Scholar
• Duer-Jensen A, Hørslev-Petersen K, Hetland ML, et al. Bone edema on magnetic resonance imaging is an independent predictor of rheumatoid arthritis development in patients with early undifferentiated arthritis. Arthritis Rheum. 2011;63(8):2192–2202.
   PubMed Web of Science ®Google Scholar